Chimeric Therapeutics Limited (CHM.AX)
AUD 0.01
(0.0%)
AUD 0.01
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | -12.52 Million AUD | 51.65% |
| 2023 | -25.91 Million AUD | -77.23% |
| 2022 | -14.62 Million AUD | 3.24% |
| 2021 | -15.11 Million AUD | -23512.59% |
| 2020 | -64 Thousand AUD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | -7.48 Million AUD | -406.34% |
| 2024 FY | -12.52 Million AUD | 51.65% |
| 2024 Q2 | 2.44 Million AUD | 100.0% |
| 2024 Q1 | 1.22 Million AUD | 108.62% |
| 2024 Q4 | -14.97 Million AUD | -100.0% |
| 2023 Q1 | -5.87 Million AUD | 5.41% |
| 2023 Q2 | -11.74 Million AUD | -100.0% |
| 2023 Q4 | -14.16 Million AUD | -100.0% |
| 2023 Q3 | -7.08 Million AUD | 39.69% |
| 2023 FY | -25.91 Million AUD | -77.23% |
| 2022 Q4 | -6.2 Million AUD | -100.0% |
| 2022 Q3 | -3.1 Million AUD | 67.96% |
| 2022 Q2 | -9.68 Million AUD | -100.0% |
| 2022 Q1 | -4.84 Million AUD | 57.91% |
| 2022 FY | -14.62 Million AUD | 3.24% |
| 2021 Q4 | -11.51 Million AUD | -100.0% |
| 2021 FY | -15.11 Million AUD | -23512.59% |
| 2021 Q3 | -5.75 Million AUD | -59.74% |
| 2021 Q1 | -1.8 Million AUD | 0.0% |
| 2021 Q2 | -3.6 Million AUD | -100.0% |
| 2020 FY | -64 Thousand AUD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| AdAlta Limited | -5.38 Million AUD | -132.842% |
| Acrux Limited | -5.8 Million AUD | -116.032% |
| Amplia Therapeutics Limited | -4.5 Million AUD | -178.228% |
| Biome Australia Limited | -1.67 Million AUD | -650.2% |
| BTC Health Limited | 1.05 Million AUD | 1287.34% |
| CSL Limited | 2.64 Billion AUD | 100.474% |
| Clarity Pharmaceuticals Ltd | -42.32 Million AUD | 70.396% |
| Clinuvel Pharmaceuticals Limited | 35.63 Million AUD | 135.16% |
| Noxopharm Limited | -3.57 Million AUD | -250.18% |
| PharmAust Limited | -9.03 Million AUD | -38.722% |
| Proteomics International Laboratories Limited | -6.37 Million AUD | -96.509% |
| Prescient Therapeutics Limited | -8.23 Million AUD | -52.097% |
| PYC Therapeutics Limited | -37.72 Million AUD | 66.787% |
| Race Oncology Limited | -13.81 Million AUD | 9.331% |
| Starpharma Holdings Limited | -8.16 Million AUD | -53.458% |
| EZZ Life Science Holdings Limited | 6.96 Million AUD | 279.911% |
| Botanix Pharmaceuticals Limited | -13.86 Million AUD | 9.66% |
| Memphasys Limited | -4.44 Million AUD | -182.075% |
| Nyrada Inc. | -1.38 Million AUD | -803.881% |
| Anatara Lifesciences Ltd | -1.45 Million AUD | -763.388% |
| Telix Pharmaceuticals Limited | 5.21 Million AUD | 340.45% |
| Bio-Gene Technology Limited | -2.4 Million AUD | -420.088% |
| Zelira Therapeutics Limited | -36.56 Million AUD | 65.736% |
| Patrys Limited | -3.53 Million AUD | -254.036% |
| Dimerix Limited | -17.07 Million AUD | 26.619% |
| Neuren Pharmaceuticals Limited | 157.08 Million AUD | 107.977% |
| Orthocell Limited | -7.18 Million AUD | -74.487% |
| Imugene Limited | -149.68 Million AUD | 91.629% |
| Cynata Therapeutics Limited | -9.74 Million AUD | -28.581% |
| Immutep Limited | -39.89 Million AUD | 68.594% |
| Arovella Therapeutics Limited | -8.74 Million AUD | -43.263% |
| Alterity Therapeutics Limited | -19.12 Million AUD | 34.479% |
| Nanollose Limited | -1.15 Million AUD | -983.379% |
| Invex Therapeutics Ltd | -1.64 Million AUD | -663.173% |
| NeuroScientific Biopharmaceuticals Limited | 324.21 Thousand AUD | 3964.732% |
| Island Pharmaceuticals Limited | -2.86 Million AUD | -337.446% |
| Biotron Limited | -3.43 Million AUD | -264.608% |
| Radiopharm Theranostics Limited | -47.94 Million AUD | 73.868% |
| Tissue Repair Ltd | -4.13 Million AUD | -202.792% |
| AnteoTech Limited | -8.88 Million AUD | -41.094% |
| Hexima Limited | -933.87 Thousand AUD | -1241.708% |
| Paradigm Biopharmaceuticals Limited | -58.65 Million AUD | 78.637% |
| Recce Pharmaceuticals Ltd | -17.66 Million AUD | 29.056% |
| Avecho Biotechnology Limited | -3.43 Million AUD | -264.604% |
| Actinogen Medical Limited | -13.04 Million AUD | 3.944% |
| Immuron Limited | -6.93 Million AUD | -80.625% |
| Argenica Therapeutics Limited | -5.47 Million AUD | -128.668% |